Keith J. Watling

2.5k total citations
60 papers, 2.1k citations indexed

About

Keith J. Watling is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Keith J. Watling has authored 60 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 39 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Keith J. Watling's work include Receptor Mechanisms and Signaling (33 papers), Neuropeptides and Animal Physiology (24 papers) and Neuroscience and Neuropharmacology Research (11 papers). Keith J. Watling is often cited by papers focused on Receptor Mechanisms and Signaling (33 papers), Neuropeptides and Animal Physiology (24 papers) and Neuroscience and Neuropharmacology Research (11 papers). Keith J. Watling collaborates with scholars based in United Kingdom, United States and Australia. Keith J. Watling's co-authors include John E. Dowling, Steven Guard, Leslie L. Iversen, Steve P. Watson, Gregory A. Hope, R. Woods, G.N. Woodruff, John L. Neumeyer, John Saunders and Rosamond G. Jackson and has published in prestigious journals such as Nature, Science and Journal of The Electrochemical Society.

In The Last Decade

Keith J. Watling

60 papers receiving 2.0k citations

Peers

Keith J. Watling
James D. Hirsch United States
John S. Shaw United Kingdom
Sally A. Thompson United States
J. Elaine Barclay United Kingdom
Keith J. Watling
Citations per year, relative to Keith J. Watling Keith J. Watling (= 1×) peers Katsunobu Takahashi

Countries citing papers authored by Keith J. Watling

Since Specialization
Citations

This map shows the geographic impact of Keith J. Watling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith J. Watling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith J. Watling more than expected).

Fields of papers citing papers by Keith J. Watling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith J. Watling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith J. Watling. The network helps show where Keith J. Watling may publish in the future.

Co-authorship network of co-authors of Keith J. Watling

This figure shows the co-authorship network connecting the top 25 collaborators of Keith J. Watling. A scholar is included among the top collaborators of Keith J. Watling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith J. Watling. Keith J. Watling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watling, Keith J., et al.. (1994). Species variants of tachykinin receptor types. Biochemical Society Transactions. 22(1). 118–122. 12 indexed citations
2.
Suman‐Chauhan, Nirmala, et al.. (1994). Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance. European Journal of Pharmacology Molecular Pharmacology. 269(1). 65–72. 28 indexed citations
3.
Guard, Steven, David C. Horwell, William Howson, et al.. (1994). Rational design of high affinity tachykinin NK2 receptor antagonists. Bioorganic & Medicinal Chemistry. 2(2). 101–113. 19 indexed citations
4.
Guard, Steven, Michael Higginbottom, David C. Horwell, et al.. (1994). Rational design of high affinity tachykinin NK1 receptor antagonists. Bioorganic & Medicinal Chemistry. 2(5). 357–370. 35 indexed citations
5.
Chung, Fu‐Zon, Maida Vartanian, Keith J. Watling, et al.. (1994). The Nonpeptide Tachykinin NK2 Receptor Antagonist SR 48968 Interacts with Human, but Not Rat, Cloned Tachykinin NK3 Receptors. Biochemical and Biophysical Research Communications. 198(3). 967–972. 24 indexed citations
6.
Guard, Steven, et al.. (1993). The interaction of the NK1 receptor antagonist CP‐96,345 with L‐type calcium channels and its functional consequences. British Journal of Pharmacology. 110(1). 385–391. 62 indexed citations
7.
Watling, Keith J., Steven Guard, James E. Krause, et al.. (1993). On the presence of NK2 receptor subtypes in peripheral and central tissues. Regulatory Peptides. 46(1-2). 311–313. 8 indexed citations
8.
Watling, Keith J. & James E. Krause. (1993). The rising sun shines on substance P and related peptides. Trends in Pharmacological Sciences. 14(3). 81–84. 53 indexed citations
9.
Guard, Steven, Keith J. Watling, & William Howson. (1993). Structure-activity requirements of bombesin for gastrin-releasing peptide- and neuromedin B-preferring bombesin receptors in rat brain. European Journal of Pharmacology. 240(2-3). 177–184. 15 indexed citations
10.
Watling, Keith J.. (1992). Nonpeptide antagonists herald new era in tachykinin research. Trends in Pharmacological Sciences. 13(7). 266–269. 72 indexed citations
11.
Guard, Steven, A.T. McKnight, Keith J. Watling, & Steve P. Watson. (1991). Evidence for Two Types of Tachykinin Receptors on Cholinergic Neurons of the Guinea Pig Ileum Myenteric Plexus a. Annals of the New York Academy of Sciences. 632(1). 400–403. 18 indexed citations
12.
Swain, Christopher J., Robert J. Baker, Clare O. Kneen, et al.. (1991). Novel 5-HT3 antagonists. Indole oxadiazoles. Journal of Medicinal Chemistry. 34(1). 140–151. 140 indexed citations
13.
Suman‐Chauhan, Nirmala, et al.. (1990). Pharmacological characterization of tachykinin‐stimulated inositol phospholipid hydrolysis in peripheral tissues. British Journal of Pharmacology. 101(4). 1001–1005. 11 indexed citations
14.
Watling, Keith J., Margaret S. Beer, Josephine A. Stanton, & Nigel R. Newberry. (1990). Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat. European Journal of Pharmacology. 182(3). 465–472. 51 indexed citations
16.
Guard, Steven, Keith J. Watling, & Steve P. Watson. (1988). Neurokinin3‐receptors are linked to inositol phospholipid hydrolysis in the guinea‐pig ileum longitudinal muscle‐myenteric plexus preparation. British Journal of Pharmacology. 94(1). 148–154. 54 indexed citations
17.
Elworthy, David, Aubrey Truman, & Keith J. Watling. (1985). The semi-classical expansion for a charged particle on a curved space background. Journal of Mathematical Physics. 26(5). 984–990. 11 indexed citations
18.
Watling, Keith J. & John E. Dowling. (1983). Effects of Vasoactive Intestinal Peptide and Other Peptides on Cyclic AMP Accumulation in Intact Pieces and Isolated Horizontal Cells of the Teleost Retina. Journal of Neurochemistry. 41(5). 1205–1213. 41 indexed citations
19.
Dowling, John E., Eric M. Lasater, Robert Van Buskirk, & Keith J. Watling. (1983). Pharmacological properties of isolated fish horizontal cells. Vision Research. 23(4). 421–432. 42 indexed citations
20.
Watling, Keith J., J. E. Dowling, & Leslie L. Iversen. (1980). Dopaminergic mechanisms in the carp retina: Effects of dopamine, K+ and light on cyclic AMP synthesis. Neurochemistry International. 1. 519–537. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026